Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gemcitabine +/- Oxaliplatin in Cisplatin-Unfit Advanced Urothelial Cancer
NCT00627432Phase 2Completed
- Sponsor
- Institut du Cancer de Montpellier
- Start
- Jul 2004
- Primary completion
- Mar 2009
- Modality
- DNA Intercalators/Alkylators
- Countries
- 1
01
Overview
A Phase 2 trial of oxaliplatin in urothelial carcinoma (UC), sponsored by Institut du Cancer de Montpellier. Started Jul 2004; status: completed.
02
Drugs
oxaliplatin
03
Conditions
urothelial carcinoma (UC)
Beyond the preview
Go deeper on NCT00627432.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00627432.